BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7899293)

  • 1. [Dysthyroidism in patients treated with interferon alpha].
    Chédin P; Chanson P; Duranteau L; Guillausseau PJ; Lubetzki J
    Presse Med; 1994 Nov; 23(36):1659-63. PubMed ID: 7899293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natural history of dysthyroidism during interferon treatment of chronic hepatitis C].
    Mekkakia-Benhabib C; Marcellin P; Colas-Linhart N; Castel-Nau C; Buyck D; Erlinger S; Bok B
    Ann Endocrinol (Paris); 1996; 57(5):419-27. PubMed ID: 8991106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of dysthyroidism during interferon therapy in chronic hepatitis C.
    Benelhadj S; Marcellin P; Castelnau C; Colas-Linhart N; Benhamou JP; Erlinger S; Bok B
    Horm Res; 1997; 48(5):209-14. PubMed ID: 9362390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis C virus, interferon alpha, and dysthyroidism].
    Marcellin P; Pouteau M; Messian O; Bok B; Erlinger S; Benhamou JP
    Gastroenterol Clin Biol; 1993; 17(12):887-91. PubMed ID: 8125219
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dysthyroidism and interferon-alpha: the withdrawal of interferon should not be systematic].
    Chédin P; Cahen-Varsaux J; Demmane S
    Gastroenterol Clin Biol; 1995 Apr; 19(4):442-4. PubMed ID: 7672530
    [No Abstract]   [Full Text] [Related]  

  • 6. Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?
    Kozielewicz D; Zaleśna A; Dybowska D
    Expert Opin Drug Saf; 2014 Aug; 13(8):1009-14. PubMed ID: 24930451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune dysthyroidism induced by alpha interferon in two female patients with chronic non-A, non-B hepatitis].
    Eugène C; Tennenbaum R; Anciaux ML; Quevauvilliers J; Bergue A
    Gastroenterol Clin Biol; 1993; 17(8-9):594-7. PubMed ID: 8253318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C.
    Gelu-Simeon M; Burlaud A; Young J; Pelletier G; Buffet C
    World J Gastroenterol; 2009 Jan; 15(3):328-33. PubMed ID: 19140232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
    Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
    Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune diseases and treatment with interferon-alpha: review of the literature apropos of a case of hyperthyroidism].
    Dupont J; Orgiazzi J; Burger A
    Rev Med Interne; 1993 Feb; 14(2):93-9. PubMed ID: 8378632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon-alpha-induced disorders of thyroid function. A retrospective analysis of the literature and personal experiences].
    Weissel M; Templ E; Gisslinger H
    Acta Med Austriaca; 1995; 22(1-2):1-5. PubMed ID: 7645363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transient thyroid dysfunction during chronic viral hepatitis treated with alpha-interferon].
    Luboshitzky R; Ayash A; Nussinson E
    Harefuah; 1995 Jan; 128(2):85-7, 127. PubMed ID: 7721181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and long-term course of thyroid dysfunction during antiviral treatments in 221 patients with chronic hepatitis C.
    Moncoucy X; Leymarie F; Delemer B; Lévy S; Bernard-Chabert B; Bouché O; Jolly D; Diebold MD; Cadiot G; Thiéfin G
    Gastroenterol Clin Biol; 2005 Apr; 29(4):339-45. PubMed ID: 15864192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
    Doi F; Kakizaki S; Takagi H; Murakami M; Sohara N; Otsuka T; Abe T; Mori M
    Liver Int; 2005 Apr; 25(2):242-6. PubMed ID: 15780045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha].
    Földes I; Dávid K; Horváth G; Osztrogonácz H; Jankovics K; Tolvaj G
    Orv Hetil; 2004 Jun; 145(23):1211-6. PubMed ID: 15264588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Disturbance in Patients with Chronic Hepatitis C Infection: A Systematic Review and Meta-analysis.
    Shen Y; Wang XL; Xie JP; Shao JG; Lu YH; Zhang S; Qin G
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):227-34. PubMed ID: 27308655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-partum dysthyroidism. Prospective study in a French region (1986-1988)].
    Mesrine S; Lécomte P; Royère D; Besnard JC; Berger C
    Ann Endocrinol (Paris); 1995; 56(6):579-84. PubMed ID: 8787348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.
    Deutsch M; Dourakis S; Manesis EK; Gioustozi A; Hess G; Horsch A; Hadziyannis S
    Hepatology; 1997 Jul; 26(1):206-10. PubMed ID: 9214471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.